Borroni B - Search Results

1

Granulin mutation drives brain damage and reorganization from preclinical to symptomatic FTLD.

Borroni B, Alberici A, Cercignani M, Premi E, Serra L, Cerini C, Cosseddu M, Pettenati C, Turla M, Archetti S, Gasparotti R, Caltagirone C, Padovani A, Bozzali M. Borroni B, et al. Neurobiol Aging. 2012 Oct;33(10):2506-20. doi: 10.1016/j.neurobiolaging.2011.10.031. Epub 2011 Nov 29. Neurobiol Aging. 2012. PMID: 22130207

2

Amyloid precursor protein in platelets of patients with Alzheimer disease: effect of acetylcholinesterase inhibitor treatment.

Borroni B, Colciaghi F, Pastorino L, Pettenati C, Cottini E, Rozzini L, Monastero R, Lenzi GL, Cattabeni F, Di Luca M, Padovani A. Borroni B, et al. Arch Neurol. 2001 Mar;58(3):442-6. doi: 10.1001/archneur.58.3.442. Arch Neurol. 2001. PMID: 11255448 Clinical Trial.

3

Abnormalities in the pattern of platelet amyloid precursor protein forms in patients with mild cognitive impairment and Alzheimer disease.

Padovani A, Borroni B, Colciaghi F, Pettenati C, Cottini E, Agosti C, Lenzi GL, Caltagirone C, Trabucchi M, Cattabeni F, Di Luca M. Padovani A, et al. Among authors: borroni b. Arch Neurol. 2002 Jan;59(1):71-5. doi: 10.1001/archneur.59.1.71. Arch Neurol. 2002. PMID: 11790233

4

Lemierre's syndrome complicated by carotid thrombosis.

Maalikjy Akkawi N, Borroni B, Magoni M, Vignolo LA, Padovani A. Maalikjy Akkawi N, et al. Among authors: borroni b. Neurol Sci. 2001 Oct;22(5):403-4. doi: 10.1007/s100720100073. Neurol Sci. 2001. PMID: 11917980

5

ApoE genotype influences the biological effect of donepezil on APP metabolism in Alzheimer disease: evidence from a peripheral model.

Borroni B, Colciaghi F, Pastorino L, Archetti S, Corsini P, Cattabeni F, Di Luca M, Padovani A. Borroni B, et al. Eur Neuropsychopharmacol. 2002 Jun;12(3):195-200. doi: 10.1016/s0924-977x(02)00013-5. Eur Neuropsychopharmacol. 2002. PMID: 12007670

6

Peripheral blood abnormalities in Alzheimer disease: evidence for early endothelial dysfunction.

Borroni B, Volpi R, Martini G, Del Bono R, Archetti S, Colciaghi F, Akkawi NM, Di Luca M, Romanelli G, Caimi L, Padovani A. Borroni B, et al. Alzheimer Dis Assoc Disord. 2002 Jul-Sep;16(3):150-5. doi: 10.1097/00002093-200207000-00004. Alzheimer Dis Assoc Disord. 2002. PMID: 12218645

7

Serum cholesterol levels modulate long-term efficacy of cholinesterase inhibitors in Alzheimer disease.

Borroni B, Pettenati C, Bordonali T, Akkawi N, Di Luca M, Padovani A. Borroni B, et al. Neurosci Lett. 2003 Jun 12;343(3):213-5. doi: 10.1016/s0304-3940(03)00336-7. Neurosci Lett. 2003. PMID: 12770699 Clinical Trial.

8

High cholesterol affects platelet APP processing in controls and in AD patients.

Borroni B, Colciaghi F, Lenzi GL, Caimi L, Cattabeni F, Di Luca M, Padovani A. Borroni B, et al. Neurobiol Aging. 2003 Sep;24(5):631-6. doi: 10.1016/s0197-4580(02)00190-2. Neurobiol Aging. 2003. PMID: 12885570

9

Platelet amyloid precursor protein abnormalities in mild cognitive impairment predict conversion to dementia of Alzheimer type: a 2-year follow-up study.

Borroni B, Colciaghi F, Caltagirone C, Rozzini L, Broglio L, Cattabeni F, Di Luca M, Padovani A. Borroni B, et al. Arch Neurol. 2003 Dec;60(12):1740-4. doi: 10.1001/archneur.60.12.1740. Arch Neurol. 2003. PMID: 14676049

10

Platelet APP, ADAM 10 and BACE alterations in the early stages of Alzheimer disease.

Colciaghi F, Marcello E, Borroni B, Zimmermann M, Caltagirone C, Cattabeni F, Padovani A, Di Luca M. Colciaghi F, et al. Among authors: borroni b. Neurology. 2004 Feb 10;62(3):498-501. doi: 10.1212/01.wnl.0000106953.49802.9c. Neurology. 2004. PMID: 14872043

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

545 results

Search Page

Filters